Researchers found that IL-1 limits advanced atherosclerosis features linked to severe complications in humans. Genetic inactivation of IL-1 signaling enhances plaque instability and reduces outward vessel remodeling in mice with advanced atherosclerosis.
Researchers found that individuals with high numbers of Ad5-reactive T cells generated a weaker immune response to HIV vaccines. This finding may impact the efficacy of future vaccines using adenoviruses other than Ad5.
Research has found that obesity is associated with neuronal injury in the hypothalamus, a crucial brain region for regulating body weight. Additionally, turnover of nerve cells in this area is inhibited by obesity, indicating a significant impact on energy balance control.
Researchers have identified a potential obstacle to developing an effective HIV vaccine: individuals with large numbers of immune cells responsive to the adenovirus used in the vaccine. Additionally, studies have found that obesity is associated with neuronal injury in the brain area crucial for body weight control and may inhibit nerv...
Researchers at Johns Hopkins University discovered that losartan, a blood pressure medication, reduces lung disease caused by cigarette smoke exposure. The study suggests other TGF-beta targeted therapeutics might be viable candidates for COPD treatment.
Researchers found that EET-enhancing drugs promote tumor growth and metastasis in mice, raising concerns about their use in humans. The findings suggest that these drugs could also worsen cardiovascular diseases.
A team of researchers found that raising levels of epoxyeicosatrienoic acids (EETs) in mice stimulated primary tumor growth and metastasis, suggesting potential risks for humans. EET antagonists may provide a new approach to preventing and treating cancer-related metastasis.
Researchers halt progressive neuron degeneration in rat model of familial ALS by switching off mutant TDP-43 expression. Recovery is possible if intervention occurs before significant motor neuron degeneration.
A team of researchers has identified markers that may enable liver transplant recipients to be weaned off their immunosuppressive drugs. Higher blood levels of iron-handling proteins and specific gene expressions in the liver can predict which patients are suitable for drug-weaning protocols.
Researchers have identified a protein that contributes to brain tumor resistance to chemotherapy, while also developing a way to predict which liver transplant patients can be weaned off immunosuppressive drugs. High levels of APNG in GBM cells correlated with poorer survival rates, suggesting it may serve as a biomarker for treatment ...
A team of researchers identified APNG as a contributor to GBM resistance to temozolomide, with high nuclear expression correlating to poorer survival. Monitoring APNG levels may provide insight into patient response to temozolomide treatment.
Researchers developed a new TB vaccine H56 that reduces clinical disease and prevents reactivation of latent infection when combined with BCG, a current but ineffective vaccine. This breakthrough could lead to improved protection against TB.
Researchers found that dental pulp stem cells can repair spinal cord injuries in rats, promoting hind limb function and nerve regeneration. A new vaccine combination boosted BCG's effectiveness against tuberculosis by reducing clinical disease and preventing reactivation of latent infection.
Researchers found that dental pulp stem cells can inhibit nerve cell death, promote nerve regeneration, and replace lost support cells in rats with severe spinal cord injuries. The study aims to translate this approach into an effective treatment for severe spinal cord injury.
Researchers have found that thyroid cancers with BRAF mutations are exquisitely dependent on the BRAF signaling pathway for viability. Treatments targeting this pathway can restore radioiodine incorporation, suggesting a new therapeutic approach for patients with BRAF-positive papillary thyroid carcinomas.
A new therapeutic target, EGFR, has been identified for treating Cushing disease. Clinical trials are necessary to investigate the effects of gefitinib in patients with this condition.
Researchers identified a new immune system defect in aged mice that makes them more susceptible to severe respiratory viral infections. Inhibiting the immune molecule PGD2 can reverse this defect, suggesting a potential therapeutic approach for older patients with severe respiratory viral infections.
Researchers identify a new way to boost the aged immune response to flu viruses by inhibiting PGD2. They also discover that targeting BRAF in thyroid cancers could restore the efficacy of RAI therapy. Additionally, exploring EGFR as a therapeutic target for Cushing disease may provide new treatment options.
A study by Bo Hu and Shi-Yuan Cheng found that PDGFR-alpha overexpression in glioblastomas triggers a signaling cascade promoting tumor growth and invasion. Manipulating Dock180 to block this pathway inhibits PDGFR-alpha's role in glioma tumorigenesis.
Researchers discovered a molecular pathway driven by PDGFR-alpha that promotes the aggressive nature of a significant proportion of glioblastomas. Overexpressed in GBMs, this pathway triggers signaling cascades leading to tumor growth and invasion. Manipulating Dock180 phosphorylation disrupts this pathway, resulting in failed tumor pr...
Researchers found that connexin 36 protects mouse pancreatic beta-cells against apoptosis triggered by immune molecules prevalent at the onset of Type 1 diabetes. Promoting connexin 36 expression and function could provide a therapeutic strategy to protect beta-cells from immune system attack.
Researchers have discovered that connexin 36 protects mouse pancreatic beta-cells against immune molecules prevalent in type 1 diabetes. Additionally, a study found that PTHrP drives breast tumor initiation, progression, and metastasis in mice, suggesting it as a potential therapy target.
Scientists discover a possible therapy for hereditary sensory and autonomic neuropathy type 1, reversing toxic molecule accumulation in mice. Additionally, researchers design minihepcidins to reduce iron overload by mimicking the natural protein's ability to lower blood iron levels.
Researchers at UCLA have developed a promising new treatment for iron overload disorders using minihepcidin peptides, which mimic the natural protein hepcidin to lower iron levels in the blood. The study provides hope for individuals affected by hereditary hemochromatosis and beta-thalassemia.
Researchers have identified a potential oral therapy for HSAN1, an inherited nerve dysfunction characterized by progressive muscle control loss. Oral administration of L-serine reversed deoxysphingolipid accumulation and reduced neuropathy severity in mice and humans with the disease.
A team of researchers has identified a non-classical form of Fetal and Neonatal Immune Thrombocytopenia (FNIT) that causes excessive platelet activation and blood clot formation in the placenta, leading to miscarriage. The condition can be prevented with intravenous IgG and anti-FcRn therapies.
Researchers have identified a non-classical form of fetal immune thrombocytopenia that can lead to miscarriage and habitual abortion. The condition is characterized by excessive platelet activation and blood clot formation in the placenta. New treatments targeting this condition have been suggested, offering hope for women affected by it.
Researchers identify broccoli-based compound as potential therapeutic for COPD, and discover the protective role of TLR6 in reducing asthma severity. Additionally, a signaling pathway linking high blood glucose to platelet hyperreactivity is defined, offering new targets for therapeutics.
Researchers identified sulforaphane as a potential therapeutic to augment anti-inflammatory effects of corticosteroids in individuals with COPD. This broccoli-based compound targets Nrf2 and restores glucocorticosteroid sensitivity in macrophages from COPD patients.
Studies reveal the role of Sirt1 in improving insulin sensitivity through caloric restriction. Researchers also identify a potential treatment approach for KRAS mutant colorectal cancers by combining receptor tyrosine kinase inhibitors with MEK inhibitors. Additionally, new insights into the cellular defects of Huntington disease are p...
Researchers have discovered that normal Htt protein regulates the formation of cilia, which are longer and disorganized in patients with Huntington disease. This finding suggests that abnormal cilia may contribute to some symptoms of the disorder.
A team of researchers has identified Sirt1 as a crucial protein linking caloric restriction to improved insulin action in skeletal muscle. This finding provides new targets for therapeutics to reduce insulin resistance and lower the risk of developing type 2 diabetes.
Researchers identified a potential combination therapy to effectively use receptor tyrosine kinases inhibitors for KRAS mutant colorectal cancers by combining with MEK/ERK signaling pathway inhibitors. This approach could offer new treatment options for individuals with KRAS mutant cancers.
A team of researchers identified a way to speed up the growth of damaged nerves, restoring muscle function in injured mice. The study suggests that increasing nerve growth rates may enhance functional recovery in patients with peripheral nerve damage.
Researchers at Stanford University School of Medicine have identified EP4 as a potential new treatment target for stroke. A selective EP4 agonist administered after stroke reduced brain damage and long-term behavioral deficits in mice, suggesting its therapeutic potential.
A team of researchers has identified a way to accelerate the regeneration of injured peripheral nerves in mice, enabling full muscle function recovery. Clinical data suggests that strategies increasing nerve growth rate may enhance functional recovery in patients after peripheral nerve damage.
Researchers have found that treating mice with OCA-1B, a form of oculocutaneous albinism, with nitisinone improves eye and skin pigmentation. The study suggests that nitisinone could potentially ameliorate vision loss in patients with OCA-1B.
Researchers identified a gene expression profile that can predict prognosis in patients with inflammatory bowel disease. The study found two subgroups of patients, one with mild disease and the other with treatment-nonresponsive disease, which will help physicians identify those who need aggressive therapies.
Researchers identified human cytomegalovirus as a potential target for treating medulloblastoma. The antiviral drug valganciclovir reduced tumor cell growth in both vitro and xenotransplantation in mice.
Researchers have found that treating mice with oculocutaneous albinism caused by mutations in the Tyr gene resulted in improved eye and hair pigmentation when treated with nitisinone. This suggests a potential new treatment for a subset of patients with OCA1B, a form of albinism associated with vision loss.
Researchers found that obese individuals' brains respond less to visual cues of high-calorie foods due to impaired glucose regulation. In contrast, non-obese individuals with normal glucose levels exhibit a stronger desire for these foods when triggered by food cues.
A study on mice shows that reducing IRS2 signaling can slow the progression of Huntington disease. Meanwhile, research also finds that circulating glucose levels can modulate neural control of desire for high-calorie foods in humans. These findings provide potential therapeutic targets and new insights into the biology of obesity.
Researchers at Harvard Medical School found that modulating Irs2 levels can slow HD progression by reducing nerve cell damage and increasing lifespan. Decreasing Irs2 levels attenuated symptoms of the disease.
Researchers discovered that mast cells release protein MCPT4, degrading Gila monster venom helodermin, reducing morbidity and mortality. This mechanism also applies to scorpion venom, providing a natural defense against deadly toxins.
Researchers at Vanderbilt University School of Medicine found that BVES regulates EMT in human colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. Restoring BVES expression decreased cancer cell characteristics.
Researchers have identified the protein BVES as a suppressor of colorectal cancer progression and suggest it could be a therapeutic or preventative target. Modulating BVES expression was found to decrease cancer cell characteristics in human colon cancer cells, providing rational for targeting BVES in individuals with colorectal cancer.
Researchers have identified a way to reduce beta-amyloid in mouse brains with AD, suggesting that activating ABCC1 transport protein could impede amyloid plaque formation. The approach uses thiethylperazine to activate ABC transporters and has potential for treating Alzheimer's disease.
Researchers identify key protein ABCCC1 in clearing Alzheimer's beta-amyloid from the brain. A mutation in PSMB8 gene causes Japanese autoinflammatory syndrome with lipodystrophy. Signaling via TACI is crucial for long-lived antibody-secreting cells in a mouse model of flu infection.
A recent study discovered that a PSMB8 gene mutation causes Japanese autoinflammatory syndrome with lipodystrophy. The researchers identified the specific mechanism of the mutation and its impact on human health.
Researchers have identified a potential new target for treating obesity by studying the molecular control of appetite in mice. Nutrient intake triggers the secretion of uroguanylin, which is then converted to uroguanylin and binds to GUCY2C receptors, leading to decreased food intake.